Discovery of a potent and selective aurora kinase inhibitor
about
Maintaining Genome Stability in Defiance of Mitotic DNA DamageFunctions of Aurora kinase C in meiosis and cancerTargeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma.A sensitive and selective liquid chromatography/tandem mass spectrometry method for determination of MLN8237 in human plasma.3D-QSAR and molecular docking studies on derivatives of MK-0457, GSK1070916 and SNS-314 as inhibitors against Aurora B kinase.Significance estimation for sequence-based chemical similarity searching (PhAST) and application to AuroraA kinase inhibitors.Update on aurora kinase inhibitors in gynecologic malignancies.Advances in fragment-based drug discovery platforms.Update on Aurora Kinase Targeted Therapeutics in Oncology.Aurora kinases as druggable targets in pediatric leukemia: heterogeneity in target modulation activities and cytotoxicity by diverse novel therapeutic agents.A molecular mechanics approach to modeling protein-ligand interactions: relative binding affinities in congeneric series.Identification of signalling cascades involved in red blood cell shrinkage and vesiculation.Aurora kinase inhibitors as anticancer molecules.The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing.Advances in Aurora kinase inhibitor patents.Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluationAurora kinase inhibitors: progress towards the clinicENMD-2076 for hematological malignancies.The Aurora kinase inhibitors in cancer research and therapy.Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy.Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine Core.Rationalizing tight ligand binding through cooperative interaction networks.Classification of Aurora-A Kinase Inhibitors Using Self-Organizing Map (SOM) and Support Vector Machine (SVM).A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation.Identification of new novel scaffold for Aurora A inhibition by pharmacophore modeling and virtual screening.Application of shape-based and pharmacophore-based in silico screens for identification of Type II protein kinase inhibitors.
P2860
Q26738970-093E47BE-4E9E-49B2-88EB-B236ADC0EE27Q26782717-5D1A20B8-C653-4410-B911-4DD0438695D2Q33709521-58658B7B-FDEB-4CB6-990A-4B8A794D9A50Q34133201-7E4F70CD-A59E-4528-9284-693E0EFE0F56Q34396024-8950F21F-F22D-4E87-AED0-3623DB55C329Q34454041-B21AEAED-8AB6-4EE8-8F66-268BD1241467Q34576017-25D5B137-001A-425A-85D5-2CFFA24BC0D8Q34616682-57AA163B-0F0C-430E-AD0B-B05683E32CABQ34941504-62725C9B-957C-4F74-930E-94FF48E44F3EQ35210664-5739E2B6-129D-417B-9AB1-E8D0611D17D7Q35243650-58E61CF2-F565-45D2-8E3E-A7770C0D8942Q35574674-490B373C-BC38-4A0F-9AB8-1E640C43B93FQ35850203-740EB751-4503-4CD8-8F2C-966E0EA5C79AQ36451580-B3B14457-665F-4164-B2DA-AD12E0C96AE3Q37481268-C1678203-1741-4583-AE87-F303330E2BE9Q37699220-60F1B9D3-279C-40B9-A715-4FD54BC05A49Q37986455-77A78D2C-46E6-4E30-84E6-E8572199211BQ37991379-B9A9E6D9-736E-4DAA-8E4C-6D92FAD8037CQ38756932-59FBE8FE-777D-4200-8416-C776B8E085E0Q38894287-69F7E643-58F5-4C38-B097-0F9B5CBB6B62Q39157474-5F15FB60-1DAC-426A-874F-3C962298D9D7Q39999558-5B7348B4-2B6E-49D1-808B-731292358A43Q47396117-57FE6060-147C-4C10-8EBE-1D05A99A5128Q49713465-E2B84593-B9EC-47C2-89A5-CCFE098FB720Q53028289-8AC02529-0FEE-47DE-87C6-C192395DCCFFQ54580789-FEC2BCED-53A5-44EC-9D61-45B984EE6A9E
P2860
Discovery of a potent and selective aurora kinase inhibitor
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Discovery of a potent and selective aurora kinase inhibitor
@ast
Discovery of a potent and selective aurora kinase inhibitor
@en
Discovery of a potent and selective aurora kinase inhibitor
@nl
type
label
Discovery of a potent and selective aurora kinase inhibitor
@ast
Discovery of a potent and selective aurora kinase inhibitor
@en
Discovery of a potent and selective aurora kinase inhibitor
@nl
prefLabel
Discovery of a potent and selective aurora kinase inhibitor
@ast
Discovery of a potent and selective aurora kinase inhibitor
@en
Discovery of a potent and selective aurora kinase inhibitor
@nl
P2093
P3181
P1476
Discovery of a potent and selective aurora kinase inhibitor
@en
P2093
Amy D Fung
Bradley T Tangonan
Chris E Lawrence
Darin A Allen
Emily J Hanan
Jeffrey A Silverman
Jeffrey W Jacobs
Johan D Oslob
P304
P3181
P356
10.1016/J.BMCL.2008.07.073
P407
P577
2008-07-24T00:00:00Z